Peptide partnership
Submitted by:
Andrew Warmington
CEM and AmbioPharm, two firms based in the Carolinas, have formed a partnership for the
Five into Heraeus accelerator programme
Submitted by:
Andrew Warmington
Following a digital pitch day and evaluation by an internal panel, Heraeus has launched its
Don’t forget your homework!
Submitted by:
Andrew Warmington
In speciality chemicals, doing your MA&D ‘homework’ means much more than it used to, says
Permira to exit CABB?
Submitted by:
Andrew Warmington
According to unconfirmed reports, private equity firm Permira is considering exiting from its ownership in
IPOs for Azelis, Nouryon
Submitted by:
Andrew Warmington
Two companies active in the speciality chemicals sector - chemicals distributor Azelis and Nouryon, the
Sasol advances with iron catalysts
Submitted by:
Andrew Warmington
Researchers from Sasol and the Catalysis Institute at the University of Cape Town (UCT) have
Orion building second China plant
Submitted by:
Andrew Warmington
Orion Engineered Carbons has begun construction of its second plant in China for speciality and
Change of owner at Seqens?
Submitted by:
Andrew Warmington
Eurazeo has announced that it has entered into exclusive discussions to sell its stake in
Lanxess to acquire IFF’s microbial control business
Submitted by:
Andrew Warmington
Lanxess has signed a corresponding agreement to acquire the microbial control business of International Flavors
Curia to expand US API capabilities
Submitted by:
Andrew Warmington
Curia has announced plans to invest about $35 million in order to expand commercial-scale API